Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jan 30;3:6. doi: 10.1186/s41747-019-0087-4

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

PMC Copyright notice

Fig. 5 — Scatter plot of tumour ADC at baseline and on follow-up for 13 patients, including 11 patients with neuroblastoma (NB), one patient with ganglioneuroblastoma (GNB) and one patient with ganglioneuroma (GN). The filled markers indicate patients who suffered tumour relapse, the markers without filling represent patients without recurrence. Of three patients with falling ADC on follow-up (below the line), two had relapsing tumours (66%). In two patients with constant ADC (on the line), there was one recurrence (50%). Among eight patients with ADC increase on follow-up (above the line), only one tumour relapsed (13%)